Skip to main content
Erschienen in: Clinical Rheumatology 11/2010

01.11.2010 | Review Article

Etiopathogenesis of Behçet's disease with emphasison the role of immunological aberrations

verfasst von: Violetta D. Kapsimali, Meletios A. Kanakis, George A. Vaiopoulos, Phaedon G. Kaklamanis

Erschienen in: Clinical Rheumatology | Ausgabe 11/2010

Einloggen, um Zugang zu erhalten

Abstract

Behçet's disease (BD) is a chronic multisystemic inflammatory disorder of unknown origin consisting of oral aphthous ulcers, ocular symptoms, skin lesions, and genital ulcerations. It has many features in common with systemic vasculitides and is more prevalent in countries along the ancient Silk route. Immune-mediated mechanisms play a major role in the pathogenesis of the disease, and inflammatory mediators are also involved. BD is not considered to be an autoimmune disorder, and the character of the disease needs to be clarified. Immunological aberrations in BD have been extensively studied by many investigators; genetic factors have been related to disease susceptibility, but their exact role in the development of disease is uncertain. Environmental factors such as infectious agents have also been implicated in the etiology of BD. However, the etiopathogenesis of the disease remains to be elucidated. Factors involved in the immunopathogenesis of BD with emphasis on the role of immunological aberrations are analyzed in this review.
Literatur
1.
Zurück zum Zitat Kaklamani VG, Vaiopoulos G, Kaklamanis P (1998) Behçet's disease. Semin Arthritis Rheum 27:197–217CrossRefPubMed Kaklamani VG, Vaiopoulos G, Kaklamanis P (1998) Behçet's disease. Semin Arthritis Rheum 27:197–217CrossRefPubMed
2.
Zurück zum Zitat Calamia KT, Wilson FC, Icen M, Crowson CS, Gabriel SE, Kremers HM (2009) Epidemiology and clinical characteristics of Behçet's disease in the United States: a population-based study. Arthritis Rheum 61:600–604CrossRefPubMed Calamia KT, Wilson FC, Icen M, Crowson CS, Gabriel SE, Kremers HM (2009) Epidemiology and clinical characteristics of Behçet's disease in the United States: a population-based study. Arthritis Rheum 61:600–604CrossRefPubMed
3.
Zurück zum Zitat Azizlerli G, Kose AA, Sarica R, Gul A, Tutkun IT, Kylac M et al (2003) Prevalence of Behçet's disease in Instanbul, Turkey. Int J Dermatol 42:803–806CrossRefPubMed Azizlerli G, Kose AA, Sarica R, Gul A, Tutkun IT, Kylac M et al (2003) Prevalence of Behçet's disease in Instanbul, Turkey. Int J Dermatol 42:803–806CrossRefPubMed
4.
Zurück zum Zitat Zouboulis CC, May T (2003) Pathogenesis of Adamantiades-Behçet's disease. Med Microbiol Immunol 192:149–155CrossRefPubMed Zouboulis CC, May T (2003) Pathogenesis of Adamantiades-Behçet's disease. Med Microbiol Immunol 192:149–155CrossRefPubMed
5.
Zurück zum Zitat Gul A (2001) Behçet's disease: an update on the pathogenesis. Clin Exp Rheumatol 19(Suppl 24):S6–S12PubMed Gul A (2001) Behçet's disease: an update on the pathogenesis. Clin Exp Rheumatol 19(Suppl 24):S6–S12PubMed
6.
Zurück zum Zitat Protogerou AD, Sfikakis PP, Stamatelopoulos KS, Papamichael C, Aznaouridis K, Karatzis E et al (2007) Interrelated modulation of endothelial function in Behçet's disease by clinical activity and corticosteroid treatment. Arthritis Res Ther 9:R90CrossRefPubMed Protogerou AD, Sfikakis PP, Stamatelopoulos KS, Papamichael C, Aznaouridis K, Karatzis E et al (2007) Interrelated modulation of endothelial function in Behçet's disease by clinical activity and corticosteroid treatment. Arthritis Res Ther 9:R90CrossRefPubMed
7.
Zurück zum Zitat Hatemi G, Fresko I, Tascilar K, Yazici H (2008) Increased enthesopathy among Behçet's syndrome patients with acne and arthritis: an ultrasonography study. Arthritis Rheum 58:1539–1545CrossRefPubMed Hatemi G, Fresko I, Tascilar K, Yazici H (2008) Increased enthesopathy among Behçet's syndrome patients with acne and arthritis: an ultrasonography study. Arthritis Rheum 58:1539–1545CrossRefPubMed
8.
Zurück zum Zitat Yazici H, Fresko I (2005) Behçet's disease and other autoinflammatory conditions: what's in a name? Clin Exp Rheumatol 23(suppl 38):S1–S2PubMed Yazici H, Fresko I (2005) Behçet's disease and other autoinflammatory conditions: what's in a name? Clin Exp Rheumatol 23(suppl 38):S1–S2PubMed
9.
Zurück zum Zitat Aksu K, Kabasakal Y, Sayiner A, Keser G, Oksel F, Bilgic A et al (1999) Prevalence of hepatitis A, B, C and E viruses in Behçet's disease. Rheumatology 38:1279–1281CrossRefPubMed Aksu K, Kabasakal Y, Sayiner A, Keser G, Oksel F, Bilgic A et al (1999) Prevalence of hepatitis A, B, C and E viruses in Behçet's disease. Rheumatology 38:1279–1281CrossRefPubMed
10.
Zurück zum Zitat Lehner T (1997) The role of heat shock protein, microbial and autiimmune agents in the aetiology of Behçet's disease. Int Rev Immun 14:21–32 Lehner T (1997) The role of heat shock protein, microbial and autiimmune agents in the aetiology of Behçet's disease. Int Rev Immun 14:21–32
11.
Zurück zum Zitat Baskan EB, Yilmaz E, Saricaoglu H, Alkan G, Ercan I, Mistik R et al (2007) Detection of parvovirus B19 DNA in the lesional skin of patients with Behçet's disease. Clin Exp Dermatol 32:186–190CrossRefPubMed Baskan EB, Yilmaz E, Saricaoglu H, Alkan G, Ercan I, Mistik R et al (2007) Detection of parvovirus B19 DNA in the lesional skin of patients with Behçet's disease. Clin Exp Dermatol 32:186–190CrossRefPubMed
12.
Zurück zum Zitat Ersoy O, Ersoy R, Yayar O, Demirci H, Tatlican S (2007) H. pylori infections in patients with Behçet's disease. World J Gastroenterol 13:2983–2985PubMed Ersoy O, Ersoy R, Yayar O, Demirci H, Tatlican S (2007) H. pylori infections in patients with Behçet's disease. World J Gastroenterol 13:2983–2985PubMed
13.
Zurück zum Zitat Ayaslioglu E, Duzgun N, Erkek E, Inal A (2004) Evidence of chronic Chlamydia pneumoniae infection in patients with Behçet's disease. Scand J Infect Dis 36:428–430CrossRefPubMed Ayaslioglu E, Duzgun N, Erkek E, Inal A (2004) Evidence of chronic Chlamydia pneumoniae infection in patients with Behçet's disease. Scand J Infect Dis 36:428–430CrossRefPubMed
14.
Zurück zum Zitat Kaneko F, Oyama N, Nishibu A (1997) Streptococcal infection in the pathogenesis of Behçet's disease and clinical effects of minocycline on the disease symptoms. Yonsei Med J 38:444–454PubMed Kaneko F, Oyama N, Nishibu A (1997) Streptococcal infection in the pathogenesis of Behçet's disease and clinical effects of minocycline on the disease symptoms. Yonsei Med J 38:444–454PubMed
15.
Zurück zum Zitat Isogai E, Hirata M, Isogai H, Matuo K, Kimura K, Yokota K et al (2003) Antimicrobial activity of synthetic human CAP 18 peptides to Streptococcus sanguis isolated from patients with Behcet's disease. Adv Exp Med Biol 528:195–200CrossRefPubMed Isogai E, Hirata M, Isogai H, Matuo K, Kimura K, Yokota K et al (2003) Antimicrobial activity of synthetic human CAP 18 peptides to Streptococcus sanguis isolated from patients with Behcet's disease. Adv Exp Med Biol 528:195–200CrossRefPubMed
16.
Zurück zum Zitat Mochizuki M, Suzuki N, Takeno M, Nagafuchi H, Harada T, Kaneoka H et al (1994) Fine antigen specificity of human gamma delta T cell lines (V gamma 9+) established by repetitive stimulation with a serotype (KTH-1) of a gram positive bacterium Streptococcus sanguis. Eur J Immunol 24:1536–1543CrossRefPubMed Mochizuki M, Suzuki N, Takeno M, Nagafuchi H, Harada T, Kaneoka H et al (1994) Fine antigen specificity of human gamma delta T cell lines (V gamma 9+) established by repetitive stimulation with a serotype (KTH-1) of a gram positive bacterium Streptococcus sanguis. Eur J Immunol 24:1536–1543CrossRefPubMed
17.
Zurück zum Zitat Karacayli U, Mumcu G, Simsek I, Pay S, Kose O, Erdem H et al (2009) The close association between dental and periodontal treatments and oral ulcers course in Behçet's disease: a perspective clinical study. J Oral Pathol Med 38:410–415CrossRefPubMed Karacayli U, Mumcu G, Simsek I, Pay S, Kose O, Erdem H et al (2009) The close association between dental and periodontal treatments and oral ulcers course in Behçet's disease: a perspective clinical study. J Oral Pathol Med 38:410–415CrossRefPubMed
18.
Zurück zum Zitat Krause I, Monselise Y, Milo G, Weinberger A (2002) Anti-Saccharomyces cerevisiae antibodies—a novel serologic marker of Behçet's disease. Clin Exp Rheumatol 20(suppl26):S-21–S-24 Krause I, Monselise Y, Milo G, Weinberger A (2002) Anti-Saccharomyces cerevisiae antibodies—a novel serologic marker of Behçet's disease. Clin Exp Rheumatol 20(suppl26):S-21–S-24
19.
Zurück zum Zitat Filik L, Biyikoglu I (2008) Differentiation of Behcet's disease from inflammatory bowel diseases: anti-Saccharomyces cerevisiae antibody and anti-neutrophilic cytoplasmic antibody. World J Gastroenterol 14:7271CrossRefPubMed Filik L, Biyikoglu I (2008) Differentiation of Behcet's disease from inflammatory bowel diseases: anti-Saccharomyces cerevisiae antibody and anti-neutrophilic cytoplasmic antibody. World J Gastroenterol 14:7271CrossRefPubMed
20.
Zurück zum Zitat Ergun T, Ince U, Eksioglu-Demiralp E, Direskeneli H, Gurbuz O, Gurses L et al (2001) HSP60 expression in mucocutaneous lesions of Behçet's disease. J Am Acad Dermatol 45:904–909CrossRefPubMed Ergun T, Ince U, Eksioglu-Demiralp E, Direskeneli H, Gurbuz O, Gurses L et al (2001) HSP60 expression in mucocutaneous lesions of Behçet's disease. J Am Acad Dermatol 45:904–909CrossRefPubMed
21.
Zurück zum Zitat Pervin K, Childerstone A, Shinnick T, Mizushima Y, van der Zee R, Hasan A, Vaughan R, Lehner T (1993) T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease. J Immunol 151:2273–2282PubMed Pervin K, Childerstone A, Shinnick T, Mizushima Y, van der Zee R, Hasan A, Vaughan R, Lehner T (1993) T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease. J Immunol 151:2273–2282PubMed
22.
Zurück zum Zitat Direskeneli H, Saruhan-Direskeneli G (2003) The role of heat shock proteins in Behçet's disease. Clin Exp Rheumatol 21:S44–S48PubMed Direskeneli H, Saruhan-Direskeneli G (2003) The role of heat shock proteins in Behçet's disease. Clin Exp Rheumatol 21:S44–S48PubMed
23.
Zurück zum Zitat Birtas-Atesoglu E, Inanc N, Yavuz S, Ergun T, Direskeneli H (2008) Serum levels of free heat shock protein 70 and anti-HSP70 and elevated in Behçet's disease. Clin Exp Rheumatol 26(suppl 50):S96–S98PubMed Birtas-Atesoglu E, Inanc N, Yavuz S, Ergun T, Direskeneli H (2008) Serum levels of free heat shock protein 70 and anti-HSP70 and elevated in Behçet's disease. Clin Exp Rheumatol 26(suppl 50):S96–S98PubMed
24.
Zurück zum Zitat Triolo G, Accardo-Palumbo A, Dieli F, Ciccia F, Ferrante A, Giardina E, Sano CD, Licata G (2003) Vgamma9/Vdelta2 T lymphocytes in Italian patients with Behçet's disease-evidence for expansion and tumor necrosis factor receptor II and interleukin-12 receptor beta1 expression in active disease. Arthritis Res Ther 5:R262–R268CrossRefPubMed Triolo G, Accardo-Palumbo A, Dieli F, Ciccia F, Ferrante A, Giardina E, Sano CD, Licata G (2003) Vgamma9/Vdelta2 T lymphocytes in Italian patients with Behçet's disease-evidence for expansion and tumor necrosis factor receptor II and interleukin-12 receptor beta1 expression in active disease. Arthritis Res Ther 5:R262–R268CrossRefPubMed
25.
Zurück zum Zitat Bank I, Duvdevani M, Livneh A (2003) Expansion of gammadelta T cells in Behçet's disease: role of disease activity and microbial flora in oral ulcers. J Lab Clin Med 141:33–40CrossRefPubMed Bank I, Duvdevani M, Livneh A (2003) Expansion of gammadelta T cells in Behçet's disease: role of disease activity and microbial flora in oral ulcers. J Lab Clin Med 141:33–40CrossRefPubMed
26.
Zurück zum Zitat Hamzaoui K, Hamzaoui A, Hentati F, Kahan A, Ayed K, Chabbou A, Ben Hamida M, Hamza M (1994) Phenotype and functional profile of T cells expressing gammadelta receptor patients with active Behçet's disease. J Rheumatol 21:2301–2306PubMed Hamzaoui K, Hamzaoui A, Hentati F, Kahan A, Ayed K, Chabbou A, Ben Hamida M, Hamza M (1994) Phenotype and functional profile of T cells expressing gammadelta receptor patients with active Behçet's disease. J Rheumatol 21:2301–2306PubMed
27.
Zurück zum Zitat Yasuoka H, Yamaguchi Y, Mizuki N, Nishida T, Kawakami Y, Kuwana M (2008) Preferential activation of circulating CD8+ and gammadelta T cells in patients with active Behçet's disease and HLA-B51. Clin Exp Rheumatol 26(suppl 50):S59–S63PubMed Yasuoka H, Yamaguchi Y, Mizuki N, Nishida T, Kawakami Y, Kuwana M (2008) Preferential activation of circulating CD8+ and gammadelta T cells in patients with active Behçet's disease and HLA-B51. Clin Exp Rheumatol 26(suppl 50):S59–S63PubMed
28.
Zurück zum Zitat Eksioglu-Demiralp E, Direskeneli H, Kibaroglu A, Yavuz S, Ergun T, Akoglu T (2001) Neutrophil activation in Behçet's disease. Clin Exp Rheumatol 19(Suppl 24):S19–S24PubMed Eksioglu-Demiralp E, Direskeneli H, Kibaroglu A, Yavuz S, Ergun T, Akoglu T (2001) Neutrophil activation in Behçet's disease. Clin Exp Rheumatol 19(Suppl 24):S19–S24PubMed
29.
Zurück zum Zitat Pay S, Simşek I, Erdem H, Dinç A (2007) Immunopathogenesis of Behçet's disease with special emphasize on the possible role of antigen presenting cells. Rheumatol Int 27:417–424CrossRefPubMed Pay S, Simşek I, Erdem H, Dinç A (2007) Immunopathogenesis of Behçet's disease with special emphasize on the possible role of antigen presenting cells. Rheumatol Int 27:417–424CrossRefPubMed
30.
Zurück zum Zitat Carletto A, Pacor ML, Biasi D, Caramaschi P, Zeminian S, Bellavite P, Bambara LM (1997) Changes of neutrophil migration without modification of in vitro metabolism and adhesion in Behçet's disease. J Rheumatol 24:1332–1336PubMed Carletto A, Pacor ML, Biasi D, Caramaschi P, Zeminian S, Bellavite P, Bambara LM (1997) Changes of neutrophil migration without modification of in vitro metabolism and adhesion in Behçet's disease. J Rheumatol 24:1332–1336PubMed
31.
Zurück zum Zitat Zouboulis CC, Katsantonis J, Ketteler R, Treudler R, Kaklamani E, Hornemann S, Kaklamanis P, Orfanos CE (2000) Adamantiades-Behçet's disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch Dermatol Res 292:279–284CrossRefPubMed Zouboulis CC, Katsantonis J, Ketteler R, Treudler R, Kaklamani E, Hornemann S, Kaklamanis P, Orfanos CE (2000) Adamantiades-Behçet's disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch Dermatol Res 292:279–284CrossRefPubMed
32.
Zurück zum Zitat Katsantonis J, Adler Y, Orfanos CE, Zouboulis CC (2000) Adamantiades-Behçet's disease: serum IL-8 is a more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate. Dermatology 201:37–39CrossRefPubMed Katsantonis J, Adler Y, Orfanos CE, Zouboulis CC (2000) Adamantiades-Behçet's disease: serum IL-8 is a more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate. Dermatology 201:37–39CrossRefPubMed
33.
Zurück zum Zitat Frassanito MA, Dammacco R, Cafforio P, Dammacco F (1999) Th1 polarization of the immune response in Behçet's disease. Arthritis Rheum 42:1967–1974CrossRefPubMed Frassanito MA, Dammacco R, Cafforio P, Dammacco F (1999) Th1 polarization of the immune response in Behçet's disease. Arthritis Rheum 42:1967–1974CrossRefPubMed
34.
Zurück zum Zitat Ben Ahmed M, Houman H, Miled M, Dellagi K, Louzir H (2004) Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's disease. Arthritis Rheum 50(7):2291–2295CrossRefPubMed Ben Ahmed M, Houman H, Miled M, Dellagi K, Louzir H (2004) Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's disease. Arthritis Rheum 50(7):2291–2295CrossRefPubMed
35.
Zurück zum Zitat Protogerou A, Lekakis J, Stamatelopoulos K, Aznaouridis K, Karatzis E, Ikonomidis I et al (2003) Arterial wall characteristics in patients with Adamantiades-Behcet's disease. Adv Exp Med Biol 528:399–404CrossRefPubMed Protogerou A, Lekakis J, Stamatelopoulos K, Aznaouridis K, Karatzis E, Ikonomidis I et al (2003) Arterial wall characteristics in patients with Adamantiades-Behcet's disease. Adv Exp Med Biol 528:399–404CrossRefPubMed
36.
Zurück zum Zitat Ozdemir R, Barutcu I, Sezgin AT, Acikgoz N, Ermis N, Metin A et al (2004) Vascular endothelial function and plasma homocysteine levels in Behcet's disease. Am J Cardiol 94:522–525CrossRefPubMed Ozdemir R, Barutcu I, Sezgin AT, Acikgoz N, Ermis N, Metin A et al (2004) Vascular endothelial function and plasma homocysteine levels in Behcet's disease. Am J Cardiol 94:522–525CrossRefPubMed
37.
Zurück zum Zitat Leiba M, Sidi Y, Gur H, Leiba A, Ehrenfeld M (2001) Behçet's disease and thrombophilia. Ann Rheum Dis 60:1081–1085CrossRefPubMed Leiba M, Sidi Y, Gur H, Leiba A, Ehrenfeld M (2001) Behçet's disease and thrombophilia. Ann Rheum Dis 60:1081–1085CrossRefPubMed
38.
Zurück zum Zitat Fadini GP, Tognon S, Rodriguez L, Boscaro E, Baesso I, Avogaro A et al (2009) Low levels of endothelial progenitor cells correlate with disease duration and activity in patients with Behçet's disease. Clin Exp Rheumatol 27:814–821PubMed Fadini GP, Tognon S, Rodriguez L, Boscaro E, Baesso I, Avogaro A et al (2009) Low levels of endothelial progenitor cells correlate with disease duration and activity in patients with Behçet's disease. Clin Exp Rheumatol 27:814–821PubMed
39.
Zurück zum Zitat Espinosa G, Font J, Tassies D, Viddaler A, Deulofeu R, Lopez-Soto A (2002) Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation and thrombomodulin. Am J Med 112:37–43CrossRefPubMed Espinosa G, Font J, Tassies D, Viddaler A, Deulofeu R, Lopez-Soto A (2002) Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation and thrombomodulin. Am J Med 112:37–43CrossRefPubMed
40.
Zurück zum Zitat Menashi S, Tribout B, Dosquet C, Le Toumelin P, Piette JC, Wechsler B et al (2008) Strong association between plasma thrombomodulin and pathergy test in Behçet's disease. Ann Rheumatol Dis 67:892–893CrossRef Menashi S, Tribout B, Dosquet C, Le Toumelin P, Piette JC, Wechsler B et al (2008) Strong association between plasma thrombomodulin and pathergy test in Behçet's disease. Ann Rheumatol Dis 67:892–893CrossRef
41.
Zurück zum Zitat Ozkan Y, Yardim-Akaydin S, Sepici A, Engin B, Sepici V, Simsek B (2007) Assessement of homocysteine, neopterin and nitric oxide levels in Behçet's disease. Clin Chem Lab Med 45:73–77CrossRefPubMed Ozkan Y, Yardim-Akaydin S, Sepici A, Engin B, Sepici V, Simsek B (2007) Assessement of homocysteine, neopterin and nitric oxide levels in Behçet's disease. Clin Chem Lab Med 45:73–77CrossRefPubMed
42.
Zurück zum Zitat Dinc A, Takafuta T, Jiang D, Melikoglu M, Saruhan-Direskeneli G, Shapiro SS (2003) Antiendothelial cell antibodies in Behçet's disease. Clin Exp Rheumatol 21(suppl 30):S27–S30PubMed Dinc A, Takafuta T, Jiang D, Melikoglu M, Saruhan-Direskeneli G, Shapiro SS (2003) Antiendothelial cell antibodies in Behçet's disease. Clin Exp Rheumatol 21(suppl 30):S27–S30PubMed
43.
Zurück zum Zitat Lee KH, Chung HS, Kim HS, Oh SH, Ha MK, Baik JH et al (2003) Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease. Arthritis Rheum 46:2025–2035CrossRef Lee KH, Chung HS, Kim HS, Oh SH, Ha MK, Baik JH et al (2003) Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease. Arthritis Rheum 46:2025–2035CrossRef
44.
Zurück zum Zitat Kalayciyan A, Zouboulis C (2007) An update on Behçet's disease. J Eur Acad Dermatol Venereol 21:1–10CrossRefPubMed Kalayciyan A, Zouboulis C (2007) An update on Behçet's disease. J Eur Acad Dermatol Venereol 21:1–10CrossRefPubMed
45.
Zurück zum Zitat Musabak U, Baylan O, Cetin T, Yesilova Z, Sengul A, Saglam K et al (2005) Lipid profile and anticardiolipin antibodies in Behçet's disease. Arch Med Res 36:387–392CrossRefPubMed Musabak U, Baylan O, Cetin T, Yesilova Z, Sengul A, Saglam K et al (2005) Lipid profile and anticardiolipin antibodies in Behçet's disease. Arch Med Res 36:387–392CrossRefPubMed
46.
Zurück zum Zitat Kandolf-Sekulovic L, Pavlovic MD, Glisic B, Petronijevic M, Ristic G, Mijuskovic Z et al (2005) Adamantiades-Behçet's disease, deep venous thrombosis and anticardiolipin antibodies: report of two cases. J Eur Acad Dermatol Venereol 19:484–488CrossRefPubMed Kandolf-Sekulovic L, Pavlovic MD, Glisic B, Petronijevic M, Ristic G, Mijuskovic Z et al (2005) Adamantiades-Behçet's disease, deep venous thrombosis and anticardiolipin antibodies: report of two cases. J Eur Acad Dermatol Venereol 19:484–488CrossRefPubMed
48.
Zurück zum Zitat Mor F, Weinberger A, Cohen IR (2002) Identification of alpha tropomyosin as a target self-antigen in Behçet's syndrome. Eur J Immunol 32:356–365CrossRefPubMed Mor F, Weinberger A, Cohen IR (2002) Identification of alpha tropomyosin as a target self-antigen in Behçet's syndrome. Eur J Immunol 32:356–365CrossRefPubMed
49.
Zurück zum Zitat Lu Y, Ye P, Chen SL, Ten EM, Chen EK (2005) Identification of kinektin as a novel Behçet's disease autoantigen. Arthritis Res Ther 7:R1133–R1139CrossRefPubMed Lu Y, Ye P, Chen SL, Ten EM, Chen EK (2005) Identification of kinektin as a novel Behçet's disease autoantigen. Arthritis Res Ther 7:R1133–R1139CrossRefPubMed
50.
Zurück zum Zitat Zervas J, Vayopoulos G, Sakellaropoulos N, Kaklamanis P, Fessas P (1988) HLA antigens and Adamantiades-Behçet's disease (ABD) in Greeks. Clin Exp Rheumatol 6:277–280PubMed Zervas J, Vayopoulos G, Sakellaropoulos N, Kaklamanis P, Fessas P (1988) HLA antigens and Adamantiades-Behçet's disease (ABD) in Greeks. Clin Exp Rheumatol 6:277–280PubMed
51.
Zurück zum Zitat Kaya TI, Dur H, Tursen U, Gurler A (2002) Association of class I HLA antigens with the clinical manifestations of Turkish patients with Behçet's disease. Clin Exp Dermatol 27:498–501CrossRefPubMed Kaya TI, Dur H, Tursen U, Gurler A (2002) Association of class I HLA antigens with the clinical manifestations of Turkish patients with Behçet's disease. Clin Exp Dermatol 27:498–501CrossRefPubMed
52.
Zurück zum Zitat Mizuki N, Yabuki K, Ota M, Katsuyama Y, Ando H, Nomura E et al (2002) Microsatellite polymorhism around the HLA-B locus in Iranian patients with Behçet's disease. Tissue Antigens 60:396–399CrossRefPubMed Mizuki N, Yabuki K, Ota M, Katsuyama Y, Ando H, Nomura E et al (2002) Microsatellite polymorhism around the HLA-B locus in Iranian patients with Behçet's disease. Tissue Antigens 60:396–399CrossRefPubMed
53.
Zurück zum Zitat Meguro A, Inoko H, Ota M, Katsuyama Y, Oka A, Okada E, et al (2010) Genetics of Behçet's disease inside and outside the MHC. Ann Rheum Dis 69:747–754 Meguro A, Inoko H, Ota M, Katsuyama Y, Oka A, Okada E, et al (2010) Genetics of Behçet's disease inside and outside the MHC. Ann Rheum Dis 69:747–754
54.
Zurück zum Zitat Durrani K, Papaliodis GN (2008) The genetics of Adamantiades Behçet's disease. Semin Ophthalmol 23:73–79CrossRefPubMed Durrani K, Papaliodis GN (2008) The genetics of Adamantiades Behçet's disease. Semin Ophthalmol 23:73–79CrossRefPubMed
55.
Zurück zum Zitat Direskeneli H (2001) Behçet's disease: infectious aetiology, new autoantigens and HLA-B51. Ann Rheum Dis 60:996–1002CrossRefPubMed Direskeneli H (2001) Behçet's disease: infectious aetiology, new autoantigens and HLA-B51. Ann Rheum Dis 60:996–1002CrossRefPubMed
56.
Zurück zum Zitat Ahmad T, Wallace GR, James T, Neville M, Bunce M, Mulcahy-Hawes K et al (2003) Mapping of the HLA association in Behçet's disease. A role for tumor necrosis factor polymorphisms? Arthritis Rheum 48:807–813CrossRefPubMed Ahmad T, Wallace GR, James T, Neville M, Bunce M, Mulcahy-Hawes K et al (2003) Mapping of the HLA association in Behçet's disease. A role for tumor necrosis factor polymorphisms? Arthritis Rheum 48:807–813CrossRefPubMed
57.
Zurück zum Zitat Mizuki N, Meguro A, Tohnai I, Gul A, Ohno S, Mizuki N (2007) Association of major histocompatibility complex class I chain-related gene A and HLA-B alleles with Behçet's disease in Turkey. Jpn J Ophthalmol 51:431–436CrossRefPubMed Mizuki N, Meguro A, Tohnai I, Gul A, Ohno S, Mizuki N (2007) Association of major histocompatibility complex class I chain-related gene A and HLA-B alleles with Behçet's disease in Turkey. Jpn J Ophthalmol 51:431–436CrossRefPubMed
Metadaten
Titel
Etiopathogenesis of Behçet's disease with emphasison the role of immunological aberrations
verfasst von
Violetta D. Kapsimali
Meletios A. Kanakis
George A. Vaiopoulos
Phaedon G. Kaklamanis
Publikationsdatum
01.11.2010
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 11/2010
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-010-1491-6

Weitere Artikel der Ausgabe 11/2010

Clinical Rheumatology 11/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.